Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

LC-OCT helps accurately diagnose different types of infant hair loss without invasive methods.

Combining treatments is key to managing vitiligo effectively.

Minoxidil can help regrow hair in people with alopecia areata.

New treatments for hair loss, like JAK inhibitors, PRP, anti-androgens, and minoxidil, offer better options.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Understanding and treating alopecia areata improves patient care.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

More research is needed to find the best long-term treatments for Alopecia Areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Phloroglucinol may help improve hair loss by promoting hair growth and reducing oxidative stress.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Glehnia littoralis and Andrographis paniculata extracts can significantly boost hair growth.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted immunotherapy could be a promising new treatment for hair regrowth.